Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -59.35% is in line with its 5-year average of -65.68%, near the high end of its 5-year range (-259.14%–-16.65%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.22% above its 12-month average of -62.62%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -59.35%.
RETURN ON INVESTED CAPITAL (ROIC)
-59.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-62.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-53.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-65.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+5.22%
CURRENT VS 3Y AVG
-10.62%
CURRENT VS 5Y AVG
+9.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.10%
median of 759 covered companies
CURRENT VS SECTOR MEDIAN
-74.04%
vs the sector median at left
Satellos Bioscience Inc.
Market Cap
$10.34M
Return on Invested Capital (ROIC)
-59.35%
TTM Avg
-62.62%
3Y Avg
-53.65%
5Y Avg
-65.68%
Market Cap
$10.32M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-27.20%
3Y Avg
-100.49%
5Y Avg
-187.87%
Market Cap
$10.31M
Return on Invested Capital (ROIC)
-227.67%
TTM Avg
-121.58%
3Y Avg
-92.03%
5Y Avg
-78.85%
Market Cap
$10.52M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-47.37%
3Y Avg
-38.90%
5Y Avg
-35.62%
Market Cap
$10.61M
Return on Invested Capital (ROIC)
-204.32%
TTM Avg
-100.17%
3Y Avg
-85.05%
5Y Avg
-71.75%
Market Cap
$10.06M
Return on Invested Capital (ROIC)
-269.16%
TTM Avg
-387.93%
3Y Avg
-400.47%
5Y Avg
-400.47%
Market Cap
$10.96M
Return on Invested Capital (ROIC)
-465.34%
TTM Avg
-276.05%
3Y Avg
-276.05%
5Y Avg
-276.05%
Market Cap
$9.92M
Return on Invested Capital (ROIC)
-95.42%
TTM Avg
-108.10%
3Y Avg
-72.41%
5Y Avg
-59.15%
Market Cap
$10.94M
Return on Invested Capital (ROIC)
-479.39%
TTM Avg
-317.58%
3Y Avg
-249.47%
5Y Avg
-183.14%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Satellos Bioscience Inc. (MSLE) | $10.34M | -59.35% | -62.62% | -53.65% | -65.68% |
| Polyrizon Ltd. (PLRZ)vs › | $10.32M | N/A | -27.20% | -100.49% | -187.87% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.31M | -227.67% | -121.58% | -92.03% | -78.85% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.52M | N/A | -47.37% | -38.90% | -35.62% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.61M | -204.32% | -100.17% | -85.05% | -71.75% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -269.16% | -387.93% | -400.47% | -400.47% |
| Caring Brands, Inc. (CABR)vs › | $10.96M | -465.34% | -276.05% | -276.05% | -276.05% |
| Lifeward Ltd. (LFWD)vs › | $9.92M | -95.42% | -108.10% | -72.41% | -59.15% |
| Cerenome, Inc. (CNSY)vs › | $10.94M | -479.39% | -317.58% | -249.47% | -183.14% |
| Ainos, Inc. (AIMD)vs › | $9.72M | -80.51% | -60.18% | -50.63% | -247.68% |
ROIC
-59.3%
ROE
-57.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -59.35% |
| 2026-03-31 | -42.35% |
| 2025-12-31 | -95.23% |
| 2025-09-30 | -64.68% |
| 2025-06-30 | -51.47% |
| 2025-03-31 | -43.80% |
| 2024-12-31 | -54.46% |
| 2024-09-30 | -172.53% |
| 2024-06-30 | -89.19% |
| 2024-03-31 | -64.32% |
| 2023-12-31 | -37.63% |
| 2023-09-30 | -24.69% |
| 2023-06-30 | -16.65% |
| 2023-03-31 | -190.10% |
| 2022-12-31 | -259.14% |
| 2022-09-30 | -103.83% |
| 2022-06-30 | -110.14% |
| 2022-03-31 | -70.72% |
| 2021-12-31 | -46.74% |
| 2021-09-30 | -34.54% |
| 2021-03-31 | -916.49% |
| 2020-12-31 | -283.77% |
| 2019-12-31 | -325.79% |
| 2019-09-30 | -116.72% |
| 2019-03-31 | -1329.58% |
